Laboratory Tests for COVID-19: A Review of Peer-Reviewed Publications and Implications for Clinical UIse.

Diagnostic tests for the coronavirus infection 2019 (COVID-19) are critical for prompt diagnosis, treatment and isolation to break the cycle of transmission. A positive real-time reverse-transcriptase polymerase chain reaction (RT-PCR), in conjunction with clinical and epidemiologic data, is the current standard for diagnosis, but several challenges still exist. Serological assays help to understand epidemiology better and to evaluate vaccine responses but they are unreliable for diagnosis in the acute phase of illness or assuming protective immunity. Serology is gaining attention, mainly because of convalescent plasma gaining importance as treatment for clinically worsening COVID-19 patients. We provide a narrative review of peer-reviewed research studies on RT-PCR, serology and antigen immune-assays for COVID-19, briefly describe their lab methods and discuss their limitations for clinical practice.

[1]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[2]  Xiancang Ma,et al.  The duration of viral shedding of discharged patients with severe COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  Kwok-Hung Chan,et al.  Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in SARS Patients by Enzyme-Linked Immunosorbent Assay , 2004, Journal of Clinical Microbiology.

[4]  F. Yu,et al.  Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset , 2020, European Respiratory Journal.

[5]  Susanne Pfefferle,et al.  Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[6]  Francesco Mojoli,et al.  Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department , 2020, Journal of medical virology.

[7]  T. Henry,et al.  Chest Computed Tomography for Detection of Coronavirus Disease 2019 (COVID-19): Don't Rush the Science , 2020, Annals of Internal Medicine.

[8]  A. Caliendo,et al.  Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[10]  Annals Clinical Decision Making: Using a Diagnostic Test , 2020, Annals of Internal Medicine.

[11]  Jincun Zhao,et al.  T cell-mediated immune response to respiratory coronaviruses , 2014, Immunologic Research.

[12]  M. Müller,et al.  Challenges of Convalescent Plasma Infusion Therapy in Middle East Respiratory Coronavirus Infection: A Single Centre Experience , 2018, Antiviral therapy.

[13]  P. Woo,et al.  A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus , 2015, Emerging Microbes & Infections.

[14]  G. Gore,et al.  Diagnostic Accuracy of Novel and Traditional Rapid Tests for Influenza Infection Compared With Reverse Transcriptase Polymerase Chain Reaction , 2017, Annals of Internal Medicine.

[15]  J. Mascola,et al.  A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial , 2008, Vaccine.

[16]  S. Blomqvist,et al.  Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[17]  Anita Patel,et al.  Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak — United States, December 31, 2019–February 4, 2020 , 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[18]  C. Sheridan Fast, portable tests come online to curb coronavirus pandemic , 2020, Nature Biotechnology.

[19]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[20]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[21]  Victor M Corman,et al.  Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  F. Hayden,et al.  Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Feasibility of Using Convalescent Plasma Immunotherapy for Mers-cov Infection, Saudi Arabia , 2022 .

[23]  Rui Liu,et al.  Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 , 2020, Clinica Chimica Acta.

[24]  Yiu Chung Lau,et al.  Temporal dynamics in viral shedding and transmissibility of COVID-19 , 2020, Nature Medicine.

[25]  Kwok-Hung Chan,et al.  Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens , 2020, Journal of Clinical Microbiology.

[26]  Q. Tao,et al.  Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases , 2020, Radiology.

[27]  Tara C Smith,et al.  Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19 , 2020, mBio.

[28]  O. Tsang,et al.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study , 2020, The Lancet Infectious Diseases.

[29]  C. Cunningham-Rundles,et al.  A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, Nature Medicine.

[30]  Y. Yazdanpanah,et al.  Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.

[31]  Shaoqiang Li,et al.  Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.

[32]  S. H. Kim,et al.  Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[33]  Jonathan E. Schmitz,et al.  Laboratory Diagnosis of COVID-19: Current Issues and Challenges , 2020, Journal of Clinical Microbiology.

[34]  J. Tanne Covid-19: FDA approves use of convalescent plasma to treat critically ill patients , 2020, BMJ.

[35]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[36]  Bingliang Zeng,et al.  Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? , 2020, European Journal of Radiology.

[37]  Zuowei Ni,et al.  Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infection , 2020, Journal of Microbiology, Immunology and Infection.

[38]  Keith R. Jerome,et al.  Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit , 2020, Journal of Clinical Microbiology.

[39]  P. Vollmar,et al.  Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.

[40]  Shangen Zheng,et al.  Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2 , 2020, Journal of Clinical Microbiology.

[41]  R. Guimarães,et al.  Principles and applications of polymerase chain reaction in medical diagnostic fields: a review , 2009, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[42]  Kai Zhao,et al.  A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.

[43]  Lai St Treatment of severe acute respiratory syndrome , 2005 .

[44]  A. Petherick Developing antibody tests for SARS-CoV-2 , 2020, The Lancet.

[45]  Shibo Jiang,et al.  Recent advances in the detection of respiratory virus infection in humans , 2020, Journal of medical virology.

[46]  Malik Peiris,et al.  Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia , 2020, Clinical chemistry.

[47]  Yan Peng,et al.  Effectiveness of convalescent plasma therapy in severe COVID-19 patients , 2020, Proceedings of the National Academy of Sciences.

[48]  Mario Plebani,et al.  Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19) , 2020, Clinical chemistry and laboratory medicine.

[49]  J. Guarner,et al.  Convalescent Plasma to Treat COVID-19: Possibilities and Challenges. , 2020, JAMA.

[50]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[51]  J. Papenburg,et al.  Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis , 2015, Journal of Clinical Microbiology.

[52]  Christian Drosten,et al.  Serological assays for emerging coronaviruses: Challenges and pitfalls , 2014, Virus Research.

[53]  Wei Zhang,et al.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes , 2020, Emerging microbes & infections.

[54]  Daniel M Altmann,et al.  What policy makers need to know about COVID-19 protective immunity , 2020, The Lancet.

[55]  Lei Liu,et al.  Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 , 2020, medRxiv.

[56]  Yuan Shi,et al.  Convalescent plasma as a potential therapy for COVID-19 , 2020, The Lancet Infectious Diseases.

[57]  W. Lim,et al.  The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis , 2014, The Journal of infectious diseases.

[58]  Sheng Zhang,et al.  False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrence , 2020, Journal of medical virology.

[59]  T. Ganiats,et al.  Implications of the impact of prevalence on test thresholds and outcomes: lessons from tuberculosis , 2012, BMC Research Notes.

[60]  M. Franchini,et al.  Operational protocol for donation of anti‐COVID‐19 convalescent plasma in Italy , 2020, Vox sanguinis.

[61]  G. Agrawal,et al.  Real-Time PCR: Revolutionizing Detection and Expression Analysis of Genes. , 2007, Current genomics.

[62]  Yiyan Song,et al.  Stability issues of RT‐PCR testing of SARS‐CoV‐2 for hospitalized patients clinically diagnosed with COVID‐19 , 2020, Journal of medical virology.

[63]  Qi Jin,et al.  Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[64]  Michael Libman,et al.  Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2 , 2020, Annals of Internal Medicine.

[65]  Yicheng Fang,et al.  Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR , 2020, Radiology.

[66]  Constantine A Raptis,et al.  A role for CT in COVID-19? What data really tell us so far , 2020, The Lancet.

[67]  Y. Teo,et al.  Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review , 2020, Journal of clinical medicine.

[68]  L. May,et al.  Better Tests, Better Care: Improved Diagnostics for Infectious Diseases , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  Bernhard Liebl,et al.  Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[70]  E. Petersen,et al.  SARS-CoV-2 shedding and infectivity , 2020, The Lancet.